At CUSP we believe in providing the best quality of treatment for our patients
Expert Diagnosis, Personalised Treatment & Advanced Surgical Care at CUSP Group of Surgeons
Lung cancer is one of the most common and serious cancers worldwide. It develops when abnormal cells in the lungs grow uncontrollably, forming a tumour that can interfere with normal breathing and spread to other parts of the body if left untreated. While smoking remains the leading risk factor, lung cancer can also occur in non-smokers due to genetic, environmental, and occupational factors. Early diagnosis and timely treatment significantly improve treatment outcomes and survival.
CUSP Surgeons, is a team of highly experienced and skilled surgeons dedicated to delivering advanced surgical care with precision, safety, and compassion for cervical cancer. We offer personalised treatment plans developed by a multidisciplinary team, combining advanced diagnostics, minimally invasive and robotic-assisted thoracic surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy to ensure the best possible outcomes for every patient.
What is Lung Cancer?
Lung cancer occurs when cells within the lungs undergo abnormal changes and begin multiplying uncontrollably. Over time, these cells form a tumour that can affect lung function and, if untreated, spread to nearby lymph nodes or distant organs.
The two main types of lung cancer are:
Advances in imaging, molecular testing, and minimally invasive thoracic surgery have greatly improved the diagnosis and treatment of lung cancer, allowing many patients to achieve better long-term outcomes.
What Causes Lung Cancer?
Although smoking is the leading cause of lung cancer, many individuals diagnosed with the disease have never smoked. Several environmental, occupational, and genetic factors can contribute to the development of lung cancer.
Common risk factors include:
While these risk factors increase the likelihood of developing lung cancer, not everyone with these factors will develop the disease. Regular medical evaluation is important for individuals at higher risk.
Why Early Diagnosis Matters
Lung cancer often causes few or no symptoms in its early stages, making it difficult to detect without appropriate screening or imaging. When diagnosed early, treatment is generally more effective and may allow complete surgical removal of the tumour before it spreads.
Individuals with persistent respiratory symptoms, a history of smoking, or significant risk factors should seek timely medical evaluation. Early diagnosis can improve survival rates and expand the range of available treatment options.
What are the Symptoms of Lung Cancer?
The symptoms of lung cancer vary depending on the size and location of the tumour. Common symptoms include:
Symptoms that persist for several weeks or worsen over time should be evaluated by a specialist.
How is Lung Cancer Diagnosed?
Accurate diagnosis and staging are essential for planning the most effective treatment. At CUSP Group of Surgeons, diagnosis begins with a detailed clinical assessment followed by advanced imaging and specialised investigations to determine the type, size, and extent of the tumour.
Diagnostic tests may include:
Early and accurate diagnosis enables personalised treatment planning and improves clinical outcomes.
Treatment Options for Lung Cancer
Treatment for lung cancer depends on several factors, including the type of lung cancer, its stage, tumour size and location, overall lung function, and the patient’s general health. At CUSP Group of Surgeons, every treatment plan is developed through a multidisciplinary approach, bringing together thoracic surgeons, medical oncologists, radiation oncologists, pulmonologists, radiologists, and pathologists to ensure personalised, evidence-based care.
Surgery is often the preferred treatment for patients with early-stage Non-Small Cell Lung Cancer (NSCLC) and offers the best chance of long-term cure when the cancer is confined to the lung.
Whenever appropriate, Video-Assisted Thoracoscopic Surgery (VATS) or robotic-assisted thoracic surgery may be recommended. These advanced minimally invasive techniques utilise small incisions, specialised instruments, and high-definition visualisation, allowing surgeons to perform complex lung cancer procedures with exceptional precision.
Potential benefits include:
The choice of surgical approach is individualised based on the tumour, patient health, and current evidence-based treatment guidelines.
It may be recommended:
Treatment plans are personalised to maximise effectiveness while carefully managing potential side effects.
Radiation therapy uses high-energy radiation to destroy cancer cells while preserving surrounding healthy tissue.
It may be recommended:
Modern radiation techniques allow highly precise treatment delivery while minimising damage to healthy lung tissue.
Targeted therapy is designed for patients whose tumours have specific genetic mutations. These medicines block the molecular pathways that allow cancer cells to grow and spread while causing less damage to normal cells.
Molecular testing helps determine whether a patient is suitable for targeted therapy, making treatment more personalised and effective.
Immunotherapy helps the body’s immune system recognise and attack cancer cells more effectively. It has become an important treatment option for many patients with advanced Non-Small Cell Lung Cancer and may be used alone or in combination with chemotherapy depending on the characteristics of the tumour.
Treatment recommendations are based on detailed molecular testing and internationally accepted clinical guidelines.
Follow-up Care & Pulmonary Rehabilitation
Regular follow-up is an essential part of lung cancer care. After treatment, patients require periodic clinical evaluations and imaging studies to monitor recovery, assess lung function, and detect any recurrence at an early stage.
At CUSP, follow-up care extends beyond cancer treatment. Our multidisciplinary team provides guidance on pulmonary rehabilitation, breathing exercises, smoking cessation, nutritional support, and lifestyle modifications to help patients recover safely, improve lung function, and maintain their quality of life.
Cashless Treatment & Government Health Schemes
At CUSP Group of Surgeons & CUSP Cancer Care, we believe that financial concerns should never become a barrier to receiving timely cancer treatment. Through our empanelled partner hospitals, eligible patients can access cervical cancer treatment, cancer surgery, robotic surgery, and minimally invasive procedures under various Central Government, State Government, Defence, and Public Sector healthcare schemes.
Depending on the terms and eligibility of the respective scheme, patients may benefit from cashless hospitalization or reimbursement for approved treatments.
Our dedicated team assists eligible beneficiaries throughout the process, from documentation and approvals to admission and treatment coordination, ensuring a seamless healthcare experience.
We are associated with several government healthcare schemes, including:
Coverage and eligibility are subject to the terms and conditions of the respective healthcare scheme and the empanelled hospital.
Why Choose CUSP Group of Surgeons for Lung Cancer Treatment in New Delhi?
Lung cancer treatment requires timely diagnosis, specialised surgical expertise, and a multidisciplinary approach to achieve the best possible outcomes. At CUSP Group of Surgeons, we combine advanced technology with evidence-based care to deliver personalised treatment for every patient.
Patients choose CUSP Surgeons for:
Our goal extends beyond treating cancer. We strive to restore health, improve quality of life, and help every patient return to their daily activities with confidence.
It is critical to profoundly understand what really matters to patients when it comes to disease management and treatment expectations.